 SHORT HILLS, N.J.--BUSINESS WIRE--Humanigen, Inc. Nasdaq: HGEN Humanigen, a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm announced that Cameron Durrant, Chairman CEO, will give a corporate presentation at 11:00am EDT today at the H.C. Wainwright Global Investment Conference taking place in Miami, FL, May 23-26, 2022. In his presentation Dr. Durrant will provide an update on progress towards releas 